Poging GOUD - Vrij
Local manufacturing is not just a priority— it is a national commitment
Express Pharma
|January 2026
Frehiwot Abebe, State Minister, Ministry of Health, Ethiopia, and Bhavin Mukund Mehta, Vice Chairman, Pharmexcil, discuss Ethiopia's evolving pharma ecosystem.
-
They outline the country's regulatory reforms, strategies to strengthen local manufacturing, investment- friendly policies, and future plans for capacity building and vaccine development. The conversation also highlights the growing India-Ethiopia partnership, with insights from Pharmexcil on export trends, regulatory alignment, and improving the ease of doing business
Ethiopia is undergoing significant evolution in its pharma regulatory landscape. What are the most critical regulatory reforms underway, and how do you envision international partners contributing to this transformation?
Frehiwot Abebe: Ethiopia, with a population of over 130 million, is currently reforming its local pharmaceutical manufacturing sector. More than 85 per cent of our pharma are imported, so our visit to India had two main objectives: first, to learn from India's journey in becoming a global pharma hub, and second, to promote investment opportunities in Ethiopia.
Strengthening the regulatory framework has been essential. Over the past two to three years, we have worked continuously with the World Health Organisation to meet global regulatory benchmarks. Recently, we achieved Maturity Level 3 for pharma products, which indicates that our regulatory system is now stable, reliable, and supportive of local manufacturing and export.
To create a more responsive regulatory environment, we assessed our challenges—particularly delays in responsiveness and communication. We have now digitised the entire system, enabling companies to apply online for product registration and submit all required documentation electronically.
India accounts for more than 70 per cent of our pharma imports, so during our visit we sought feedback directly from Indian investors. Some challenges they highlighted included delays in GMP inspections. We have already begun working on improving the speed and efficiency of GMP assessments.
Dit verhaal komt uit de January 2026-editie van Express Pharma.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Express Pharma
Express Pharma
Standardisation vs customisation in single-use systems for bioprocessing: What do biopharma companies need?
Priyabrata Pattnaik, CEO, Ami Polymer highlights the balance between standardisation and customisation in single - use systems in biopharma manufacturing
5 mins
May 2026
Express Pharma
Ensuring Pharma compliance with testo data measurement technology
Due to the crucial necessity and its direct impact on human health and welfare, Pharma is probably the most important and critical sector among others.
3 mins
May 2026
Express Pharma
China+1 moment for pharma: How India can convert opportunity into long-term contracts
Manish Jain, Director, Naprod Life Sciences explains how India must move beyond cost advantage to lead with reliability, quality, and transparency to reshape global pharma supply chains and position itself as a trusted, long-term partner
3 mins
May 2026
Express Pharma
Beyond scale: Rethinking new frontiers in building excellence
At the Injectable Innovations Conclave 2026, hosted by Express Pharma, industry leaders examined the trends, technologies and strategies shaping the next phase of injectable growth, reports
10 mins
May 2026
Express Pharma
Waters receives CE mark for BD BACTEC FXI Culture System under EU IVDR
Next-generation blood culture system records ~3-hour faster detection time and introduces automated blood volume measurement
2 mins
May 2026
Express Pharma
JNPC: Carrying forward a 20-year old legacy
Billed as India's first bulk drug, chemicals and allied manufacturing parks and one of the most successful public-private partnerships (PPP) in the pharma sector, the Jawaharlal Nehru Pharma City (JNPC), also known as Visakha Pharma City, was set up in February 2005 as a PPP initiative by the Govt of Andhra Pradesh (GoAP) through its nodal agency Andhra Pradesh Industrial Infrastructure Corporation (APIIC) with the Ramky Group on a Build-Own-Operate (BOO) basis for 20 years.
3 mins
May 2026
Express Pharma
Romaco's sustainable blister packaging line at interpack
At this year's interpack, the Romaco Group will present its sustainable Unity 600 high-speed blister packaging line, featuring – for the first time – the PF 75 stretch bander.
6 mins
May 2026
Express Pharma
Even drug-resistant cancer targets can be tackled with the right design strategy
Dr Bajarang Kumbhar, Assistant Professor, Sunandan Divatia School of Science, NMIMS Mumbai, explains how Al-driven computational biology is reshaping CAR-T therapy and highlights how these approaches help cut drug discovery timelines and improve targeted, personalised cancer treatment, in an interaction with Kalyani Sharma
7 mins
May 2026
Express Pharma
Navigating legal and regulatory landscape of GLP-1 drugs in India
GLP-1 drugs are drawing sharp regulatory and legal scrutiny, especially with generics entering post-patent expiry. They emphasise that navigating IP, compliance, and marketing rules is now critical for stakeholders
5 mins
May 2026
Express Pharma
From back office to brain trust: How life sciences GCCs are redefining leadership hiring in India
Sai Gandhi, Partner, Positive Moves points out that life sciences GCCs in India are moving from support roles to driving core innovation and global strategy. In turn, leadership hiring is shifting toward cross-functional, globally savvy leaders who can deliver enterprise-wide impact
4 mins
May 2026
Listen
Translate
Change font size

